Works matching IS 00071188 AND DT 2023 AND VI 180 AND IP 6
Results: 10
Expression of concern: Carrageenan‐induced mouse paw oedema is biphasic, age‐weight dependent and displays differential nitric oxide cyclooxygenase‐2 expression.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 6, p. 790, doi. 10.1111/bph.16038
- Publication type:
- Article
Expression of concern: Protective role of PI3‐kinase‐Akt‐eNOS signalling pathway in intestinal injury associated with splanchnic artery occlusion shock.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 6, p. 789, doi. 10.1111/bph.16037
- Publication type:
- Article
Correction to "An in silico‐in vitro pipeline for drug cardiotoxicity screening identifies ionic proarrhythmia mechanisms".
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 6, p. 786, doi. 10.1111/bph.16031
- Publication type:
- Article
Drug repurposing for cardiovascular diseases: New targets and indications for probenecid.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 6, p. 685, doi. 10.1111/bph.16001
- By:
- Publication type:
- Article
Analysis of inhibitors of the anoctamin‐1 chloride channel (transmembrane member 16A, TMEM16A) reveals indirect mechanisms involving alterations in calcium signalling.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 6, p. 775, doi. 10.1111/bph.15995
- By:
- Publication type:
- Article
Quantitative analysis of drug distribution in heterogeneous tissues using dual‐stacking capillary electrophoresis–mass spectrometry.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 6, p. 762, doi. 10.1111/bph.15988
- By:
- Publication type:
- Article
Artesunate, a new antimalarial clinical drug, exhibits potent anti‐AML activity by targeting the ROS/Bim and TFRC/Fe<sup>2+</sup> pathways.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 6, p. 701, doi. 10.1111/bph.15986
- By:
- Publication type:
- Article
Characterization of immune checkpoint inhibitor‐induced cardiotoxicity reveals interleukin‐17A as a driver of cardiac dysfunction after anti‐PD‐1 treatment.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 6, p. 740, doi. 10.1111/bph.15984
- By:
- Publication type:
- Article
Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 6, p. 721, doi. 10.1111/bph.15977
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 6, p. 683, doi. 10.1111/bph.15874
- Publication type:
- Article